Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc.verified

VYGR

Price:

$4.35

Market Cap:

$241.84M

Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; and Tau program for the treatment of tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, as well as for spinal muscular atrophy. The company has collaboration and license agreements with Neurocrine Biosci...[Read more]

Industry

Biotechnology

IPO Date

2015-11-11

Stock Exchange

NASDAQ

Ticker

VYGR

The ROE as of December 2025 (TTM) for Voyager Therapeutics, Inc. (VYGR) is -48.94%

According to Voyager Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -48.94%. This represents a change of 297.46% compared to the average of -12.31% of the last 4 quarters.

Voyager Therapeutics, Inc. (VYGR) Historical ROE (quarterly & annually)

How has VYGR ROE performed in the past?

The mean historical ROE of Voyager Therapeutics, Inc. over the last ten years is -42.10%. The current -48.94% ROE has changed 16.26% with respect to the historical average. Over the past ten years (40 quarters), VYGR's ROE was at its highest in in the March 2023 quarter at 57.17%. The ROE was at its lowest in in the December 2018 quarter at -48.51%.

Quarterly (TTM)
Annual

Average

-42.10%

Median

-35.30%

Minimum

-190.09%

Maximum

56.00%

Voyager Therapeutics, Inc. (VYGR) ROE by Quarter and Year

Discovering the peaks and valleys of Voyager Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 260.43%

Maximum Annual ROE = 56.00%

Minimum Annual Increase = -391.78%

Minimum Annual ROE = -190.09%

Quarterly (TTM)
Annual
YearROEChange
2024-21.68%-138.73%
202356.00%-171.21%
2022-78.63%13.19%
2021-69.47%-391.78%
202023.81%-158.02%
2019-41.03%-78.41%
2018-190.09%260.43%
2017-52.74%78.35%
2016-29.57%68.50%
2015-17.55%-98.76%

Voyager Therapeutics, Inc. (VYGR) Average ROE

How has VYGR ROE performed in the past?

The current ROE of Voyager Therapeutics, Inc. (VYGR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-14.77%

5-year avg

-18.00%

10-year avg

-42.10%

Voyager Therapeutics, Inc. (VYGR) ROE vs. Peers

How is VYGR’s ROE compared to its peers?

Voyager Therapeutics, Inc.’s ROE is greater than Atea Pharmaceuticals, Inc. (-32.55%), greater than Entrada Therapeutics, Inc. (-26.42%), less than Humacyte, Inc. (449.27%), greater than Arcturus Therapeutics Holdings Inc. (-21.51%), greater than Vanda Pharmaceuticals Inc. (-16.82%), greater than Pyxis Oncology, Inc. (-102.12%), greater than Achieve Life Sciences, Inc. (-196.68%), greater than Enanta Pharmaceuticals, Inc. (-93.76%), greater than Allogene Therapeutics, Inc. (-57.79%), greater than Sagimet Biosciences Inc. (-42.39%),

Build a custom stock screener for Voyager Therapeutics, Inc. (VYGR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Voyager Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Voyager Therapeutics, Inc. (VYGR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Voyager Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Voyager Therapeutics, Inc.'s ROE?

How is the ROE calculated for Voyager Therapeutics, Inc. (VYGR)?

What is the highest ROE for Voyager Therapeutics, Inc. (VYGR)?

What is the 3-year average ROE for Voyager Therapeutics, Inc. (VYGR)?

What is the 5-year average ROE for Voyager Therapeutics, Inc. (VYGR)?

How does the current ROE for Voyager Therapeutics, Inc. (VYGR) compare to its historical average?